Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Thoracic and Cardiovascular Surgery

• Publication date

  2011-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jtcvs.2011.02.011PMID 21429525
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dabigatran versus warfarin in patients with atrial fibrillation.

  2009cited by this paper
• Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor

  2009cited by this paper
• Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

  2009cited by this paper
• Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine.

  2008cited by this paper
• Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty

  2008cited by this paper
• New issues in oral anticoagulants.

  2008cited by this paper
• Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.

  2007cited by this paper
• Melagatran for thromboprophylaxis after mechanical valve implantation: results in a heterotopic porcine model.

  2007cited by this paper
• A model of heterotopic aortic valve replacement for studying thromboembolism prophylaxis in mechanical valve prostheses.

  2007cited by this paper
• Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

  2006cited by this paper
• Low-Molecular-Weight Heparin as a Bridging Anticoagulant Early After Mechanical Heart Valve Replacement

  2006cited by this paper
• Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement

  2006cited by this paper
• Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation.

  2005cited by this paper
• The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement.

  2005cited by this paper
• Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Sex-specific changes in platelet aggregation and secretion with sexual maturity in pigs.

  2004cited by this paper
• Fondaparinux, the first selective factor Xa inhibitor

  2003cited by this paper
• Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.

  2001cited by this paper
• Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.

  2001cited by this paper
• Current state of in vivo preclinical heart valve evaluation.

  1998cited by this paper
• Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

  1998cited by this paper
• Heparin and low-molecular weight heparins

  1992cited by this paper

• Leveling the playing field: The role of level‐based dosing in pediatric anticoagulation management

  2024cites this paper
• Difference in coagulation systems of large animal species used in cardiovascular research: a systematic review

  2024cites this paper
• A Fibrin-Thrombin Based In Vitro Perfusion System to Study Flow-Related Prosthetic Heart Valves Thrombosis

  2024cites this paper
• Is There an Alternative Oral Anticoagulation to Vitamin-K-Antagonists for Patients with Mechanical Aortic Valve Replacement? – A Literature Review

  2024cites this paper
• Histologic changes of porcine portal vein anastomosis after electrochemotherapy with bleomycin.

  2023cites this paper
• DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives

  2023cites this paper
• Peri-Interventional Triple Therapy with Dabigatran Modifies Vasomotion after Bare-Metal Stent Implantation in a Pig Coronary Artery Model

  2023cites this paper
• Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease

  2022cites this paper
• Apixaban in a porcine model of mechanical valve thrombosis in pulmonary position—a pilot study

  2022cites this paper
• Alternatives for Vitamin K Antagonists as Thromboprophylaxis for Mechanical Heart Valves and Mechanical Circulatory Support Devices: A Systematic Review

  2021cites this paper
• Predictors of Use and Outcomes of Mechanical Valve Replacement in the United States (2008–2017)

  2021cites this paper
• Secondary prevention of thrombosis with direct oral anticoagulants for hereditary hematogenous thrombophilia

  2021cites this paper
• Factor Xa Inhibitors for Patients after Mechanical Heart Valve Replacement?

  2021cites this paper
• Patient and healthcare provider burden due to conventional measurement of the international normalized ratio: From a multi-dimensional perspective

  2021cites this paper
• Peri-interventional Triple Therapy With Dabigatran Improves Vasomotion and Promotes Endothelialization in Porcine Coronary Stenting Model

  2021cites this paper
• Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve.

  2020cites this paper
• A Case of Mitral Mechanical Valve Thrombosis after Switching to Edoxaban

  2020cites this paper
• Use of NOAC in clinical practice of stroke: Expert Opinion of the Turkish Society of Cerebrovascular Diseases

  2020cites this paper
• Rationale and design of PROACT Xa: a randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban vs. warfarin in patients with a mechanical On-X® Aortic Heart Valve

  2020cites this paper
• Anticoagulation and antiplatelet therapy in patients with prosthetic heart valves

  2020cites this paper
• Rivaroxaban and dabigatran for suppression of mechanical heart valve-induced thrombin generation.

  2019cites this paper
• Rivaroxaban in patients with mechanical heart valves: A pilot study.

  2019cites this paper
• Hemocompatibility of Super-Repellent surfaces: Current and Future.

  2019cites this paper
• Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation?

  2019cites this paper
• Non–Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves: Is the Door Still Open?

  2018cites this paper
• Direct Oral Anticoagulant Use in Valvular Heart Disease

  2018cites this paper
• Evidence Gaps in the Era of Non–Vitamin K Oral Anticoagulants

  2018cites this paper
• Defining Non-Valvular Atrial Fibrillation : a Quest for Clarification

  2018cites this paper
• Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model

  2017cites this paper
• Mechanical Valve Thrombosis on Rivaroxaban: Are Novel Anticoagulants Really an Option?

  2017cites this paper
• Anticoagulation for Mechanical Heart Valves: Will Oral Factor Xa Inhibitors Be Effective?

  2017cites this paper
• Application of the Direct Oral Anticoagulants to Thromboprophylaxis of Mechanical Heart Valves

  2017cites this paper
• Hydrodynamic and coagulation characteristics of a re-engineered mechanical heart valve in an ovine model

  2017cites this paper
• Aminocaproic Acid and Tranexamic Acid Fail to Reverse Dabigatran-Induced Coagulopathy

  2016cites this paper
• PULMONARY EMBOLISM IN THE ONSET OF GENETIC HEMATOGENICAL THROMBOPHILIA

  2016cites this paper
• Defining nonvalvular atrial fibrillation: A quest for clarification.

  2016cites this paper
• New oral anti-coagulants: Implications for neurosurgery

  2015cites this paper
• Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation

  2015cites this paper
• Dabigatran etexilate - A novel oral anticoagulant for bleeding complications

  2015cites this paper
• Cardiovascular Catheterization, Electrophysiology, and Imaging Laboratory Procedures

  2015cites this paper
• Pancreas and Spleen

  2015cites this paper
• CASE 4-2014: ascending aortic pseudoaneurysm repair with deep hypothermic circulatory arrest in an adult congenital heart disease patient with heparin-induced thrombocytopenia.

  2014cites this paper
• Dabigatran for Mechanical Valves

  2014cites this paper
• Monitoring of Hematological and Hemostatic Parameters in Neurocritical Care Patients

  2014cites this paper
• Effectiveness of rivaroxaban for thromboprophylaxis of prosthetic heart valves in a porcine heterotopic valve model.

  2014influential citation
• Role of Novel Anticoagulants for Patients with Mechanical Heart Valves

  2014cites this paper
• Managing Anticoagulation in Patients with Mechanical Valves

  2014cites this paper
• Mechanische Aortenklappenprothesen

  2013cites this paper
• Mechanical heart valve thrombosis and novel oral anticoagulants: A word of caution

  2013cites this paper
• Dabigatran versus warfarin in patients with mechanical heart valves.

  2013cites this paper
• Differential profiles of thrombin inhibitors (heparin, hirudin, bivalirudin, and dabigatran) in the thrombin generation assay and thromboelastography in vitro

  2013cites this paper
• Anticoagulation for Prosthetic Valves

  2013cites this paper
• Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices.

  2013cites this paper
• Thromboembolism in a patient with a mechanical mitral valve during anticoagulation with dabigatran etexilate.

  2013cites this paper
• Fatal association of mechanical valve thrombosis with dabigatran: a report of two cases.

  2013cites this paper
• Cost-effectiveness of mitral valve repair versus replacement by biologic or mechanical prosthesis.

  2013cites this paper
• Mitral valve prosthesis choice for patients aged 65 years and over in the UK. Are the guidelines being followed and does it matter?

  2013cites this paper
• Clinical strategies for selecting oral anticoagulants in patients with atrial fibrillation

  2013cites this paper
• Die Arbeitsgemeinschaft Aortenklappenchirurgie stellt sich vor

  2012cites this paper
• New anticoagulants: A concise review

  2012cites this paper
• Warfarin and Newer Oral Anticoagulants : Long-term Prevention and Treatment of Arterial and VTE Evidence-based Synthesis Program EXECUTIVE SUMMARY BACKGROUND Thromboembolic diseases

  2012cites this paper
• Long-term self-management of anticoagulation therapy after mechanical heart valve replacement in outside trial conditions.

  2012cites this paper
• Thrombosis on a Mechanical Aortic Valve whilst Anti-coagulated With Dabigatran.

  2012cites this paper
• A Systematic Review of the Literature

  2012cites this paper
• A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN).

  2012cites this paper
• Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice

  2012cites this paper
• [Dabigatran: transforming the management of oral anticoagulation].

  2012cites this paper
• Response to Letters Regarding Article, “Using Dabigatran in Patients With Stroke: A Practical Guide for Clinicians”

  2012cites this paper
• Die Arbeitsgemeinschaft Aortenklappenchirurgie stellt sich vor

  2012cites this paper
• Nuevos anticoagulantes: dabigatrán, rivaroxabán y apixabán

  2012cites this paper
• ¿A qué pacientes beneficia el uso de dabigatrán? Uso práctico

  2012cites this paper
• [New anticoagulants: dabigatran, rivaroxaban and apixaban].

  2012cites this paper
• 10. The Discovery of Dabigatran Etexilate

  2012cites this paper
• Innovations in aortic valve therapy for elderly patients

  2012cites this paper
• Mechanical valve thrombosis with dabigatran.

  2012cites this paper
• Over the Next Hill

  2012cites this paper
• Orale Antikoagulation mit Dabigatran bei eingeschränkter Nierenfunktion

  2012cites this paper
• Silent brain infarction in patients presenting with mechanical heart valve thrombosis.

  2012cites this paper
• The Discovery of Dabigatran Etexilate

  2012cites this paper
• Using Dabigatran in Patients With Stroke: A Practical Guide for Clinicians

  2012cites this paper
• Newer Oral Anticoagulant Agents: A New Era in Medicine

  2012cites this paper
• Prevention and treatment of venous thromboembolism and pulmonary embolism: the role of novel oral anticoagulants.

  2012cites this paper
• The Year in Review: The Surgical Treatment of Valvular Disease—2011

  2012cites this paper
• Dabigatran Etexilate : Pharmacology of the New, Oral Direct Thrombin Inhibitor

  2011cites this paper
• Direct thrombin inhibitors.

  2011cites this paper
• Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.

  2011cites this paper
• Using Dabigatran in Patients With Stroke

  2011cites this paper
• Dabigatran etexilate in mechanical valve thromboprophylaxis.

  2011influential citation
• Dabigatran after cardiac surgery: caution advised.

  2011cites this paper
• Development of an Orthotopic Pulmonary Valve Replacement Porcine Model for Mechanical Heart Valve Thrombosis Research

  year unknowncites this paper